Annual Total Liabilities
$86.15 M
-$33.06 M-27.73%
December 31, 2023
Summary
- As of February 8, 2025, GTHX annual total liabilities is $86.15 million, with the most recent change of -$33.06 million (-27.73%) on December 31, 2023.
- During the last 3 years, GTHX annual total liabilities has risen by +$34.95 million (+68.27%).
Performance
GTHX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$74.10 M
-$190.00 K-0.26%
June 30, 2024
Summary
- As of February 8, 2025, GTHX quarterly total liabilities is $74.10 million, with the most recent change of -$190.00 thousand (-0.26%) on June 30, 2024.
- Over the past year, GTHX quarterly total liabilities has dropped by -$16.25 million (-17.98%).
Performance
GTHX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GTHX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.7% | -18.0% |
3 y3 years | +68.3% | -18.0% |
5 y5 years | +592.0% | +290.3% |
GTHX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.7% | at low | -38.6% | at low |
5 y | 5-year | -27.7% | -66.0% | -38.6% | -63.5% |
alltime | all time | -27.7% | -97.5% | -38.6% | -92.4% |
G1 Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $74.10 M(-0.3%) |
Mar 2024 | - | $74.29 M(-13.8%) |
Dec 2023 | $86.15 M(-27.7%) | $86.15 M(-4.4%) |
Sep 2023 | - | $90.08 M(-0.3%) |
Jun 2023 | - | $90.34 M(-22.8%) |
Mar 2023 | - | $116.97 M(-1.9%) |
Dec 2022 | $119.22 M(+7.8%) | $119.22 M(-1.2%) |
Sep 2022 | - | $120.61 M(+0.0%) |
Jun 2022 | - | $120.55 M(+2.1%) |
Mar 2022 | - | $118.11 M(+6.8%) |
Dec 2021 | $110.55 M(+115.9%) | $110.55 M(+69.7%) |
Sep 2021 | - | $65.16 M(+2.5%) |
Jun 2021 | - | $63.56 M(+0.7%) |
Mar 2021 | - | $63.12 M(+23.3%) |
Dec 2020 | $51.20 M | $51.20 M(-15.7%) |
Sep 2020 | - | $60.76 M(+22.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | $49.75 M(+83.8%) |
Mar 2020 | - | $27.06 M(-7.6%) |
Dec 2019 | $29.30 M(+135.4%) | $29.30 M(-5.7%) |
Sep 2019 | - | $31.07 M(+63.7%) |
Jun 2019 | - | $18.98 M(+49.1%) |
Mar 2019 | - | $12.73 M(+2.3%) |
Dec 2018 | $12.45 M(+5.7%) | $12.45 M(-9.5%) |
Sep 2018 | - | $13.76 M(-2.2%) |
Jun 2018 | - | $14.08 M(+11.8%) |
Mar 2018 | - | $12.59 M(+6.8%) |
Dec 2017 | $11.78 M(+109.5%) | $11.78 M(+13.1%) |
Sep 2017 | - | $10.42 M(+0.1%) |
Jun 2017 | - | $10.41 M(+25.5%) |
Mar 2017 | - | $8.30 M(+47.5%) |
Dec 2016 | $5.63 M(+159.5%) | $5.63 M |
Dec 2015 | $2.17 M | - |
FAQ
- What is G1 Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for G1 Therapeutics?
- What is G1 Therapeutics annual total liabilities year-on-year change?
- What is G1 Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for G1 Therapeutics?
- What is G1 Therapeutics quarterly total liabilities year-on-year change?
What is G1 Therapeutics annual total liabilities?
The current annual total liabilities of GTHX is $86.15 M
What is the all time high annual total liabilities for G1 Therapeutics?
G1 Therapeutics all-time high annual total liabilities is $119.22 M
What is G1 Therapeutics annual total liabilities year-on-year change?
Over the past year, GTHX annual total liabilities has changed by -$33.06 M (-27.73%)
What is G1 Therapeutics quarterly total liabilities?
The current quarterly total liabilities of GTHX is $74.10 M
What is the all time high quarterly total liabilities for G1 Therapeutics?
G1 Therapeutics all-time high quarterly total liabilities is $120.61 M
What is G1 Therapeutics quarterly total liabilities year-on-year change?
Over the past year, GTHX quarterly total liabilities has changed by -$16.25 M (-17.98%)